Active Ingredient(s): Trilaciclib Dihydrochloride
FDA Approved: * February 12, 2021
Pharm Company: * G1 THERAP
Category: Cancer

Trilaciclib, sold under the brand name Cosela, is a medication used to reduce the frequency of chemotherapy-induced bone marrow suppression.[1][2][3][4] The most common side effects include fatigue; low levels of calcium, potassium and phosphate; increased levels of an enzyme called aspartate aminotransferase; headache; and infection in the lungs (pneumonia).[2] Trilaciclib may help protect bone marrow cells from ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cosela 300 mg/20ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 73462-101
G1 Therapeutics, Inc.